GlassScriptPhysician profile
Michael A Missler
NPI 1417999467
$5,581.23
in general payments reported to CMS, 2019-2025
30 companies · $228 in 2025
The $228 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $598 · 2020: $296 · 2021: $148 · 2022: $509 · 2023: $1,014 · 2024: $2,789 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,909 · Travel and Lodging: $1,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,908.82 |
| Travel and Lodging | $1,122.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,861.13 | 2021-2024 | Micra, Corevalve Evolut R, Linq II |
| Abiomed | $498.36 | 2022-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $478.04 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $396.73 | 2021-2024 | |
| Amgen INC. | $334.69 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $299.03 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $220.75 | 2019-2025 | Brilinta, Farxiga |
| Boston Scientific Corporation | $198.74 | 2022-2024 | Synergy, Watchman Access System, Emerge Push |
| E.R. Squibb & Sons, L.L.C. | $189.14 | 2019-2025 | Eliquis, Camzyos |
| Edwards Lifesciences Corporation | $175.57 | 2023-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.56 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $110.54 | 2022-2023 | Verquvo |
| Kestra Medical Technology Services, INC. | $103.81 | 2023-2024 | Assure Wcd |
| Z-Medica, LLC | $88.30 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $59.33 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $52.70 | 2019-2023 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $42.69 | 2023-2024 | Inpefa |
| Cvrx, INC. | $38.25 | 2023-2025 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $37.63 | 2019 | |
| Acist Medical Systems, INC. | $29.91 | 2023 | |
| Teleflex LLC | $27.22 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $25.67 | 2023 | Arcalyst |
| Abbott Laboratories | $23.32 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.05 | 2025 | |
| Medtronic Vascular, INC. | $21.33 | 2020 | |
| Astellas Pharma US INC | $20.05 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $19.61 | 2019 | |
| Irhythm Technologies, INC. | $18.33 | 2023 | Zio Xt Patch |
| Ge Healthcare | $14.56 | 2019 | |
| Philips North America LLC | $12.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Missler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.